Genetic medicine startup Lyora launches with programs from Editas, Biogen

Lyora CEO Pam Stetkiewicz (L) and co-founder Luk Vandenberghe July 14, 2026 07:00 AM EDT FinancingStartups Ex­clu­sive: Ge­net­ic med­i­cine start­up launch­es to speed pro­grams that stalled at Ed­i­tas, Bio­gen Lei Lei Wu News Reporter Ly­o­ra Ther­a­peu­tics will try to re­vive sev­er­al ear­ly-stage ge­net­ic eye dis­ease pro­grams pre­vi­ous­ly held by Ed­i­tas Med­i­cine and Bio­gen. The biotech was co-found­ed by Luk … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER